Skip to product information

Michigan Medicine Updates in Lupus 2023

Michigan Medicine Updates in Lupus 2023

Regular price $30.00 USD
Regular price $30.00 USD Sale price
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
Michigan Medicine Updates in Lupus 2023

Michigan Medicine Updates in Lupus 2023

Regular price $30.00
Regular price $30.00 Sale price
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
  • Share positive thoughts and feedback from your customer.

    Author
  • Share positive thoughts and feedback from your customer.

    Author
  • Share positive thoughts and feedback from your customer.

    Author
    View full details

    Lupus Program

    The Michigan Medicine Lupus Program provides world-class care to patients with lupus, providing them with access to the latest treatments and clinical trials. A multidisciplinary group of health care professionals including rheumatologists, nephrologists, pulmonologists, dermatologists, hematologists, psychiatrists, and high-risk obstetricians and gynecologists, all with a special interest in lupus, are the backbone of this clinic.
    Specialized laboratory and ancillary services, as well as access to other specialties, are readily available to our patients.

    The Lupus Program was officially created in 2007, however, the contributing physicians have been dedicated to the specialized care of patients with lupus for decades. The University of Michigan Medical School is one of the leading institutions in the country and provides an ideal environment to serve the lupus community.

    Systemic Lupus Erythematosus (SLE) is an extraordinarily complex autoimmune rheumatic disease that occurs primarily in women of childbearing age, which is best addressed by a multidisciplinary approach to diagnosis, treatment, and research. Our program goals are to provide state-of-the-art multidisciplinary care, with a team of rheumatologists, nephrologists, pulmonologists, hematologists, dermatologists, and high-risk obstetricians and gynecologists.


    Michigan Medicine Updates in Lupus 2023 SATURDAY, NOVEMBER 18, 2023

    Program Objectives
    At the conclusion of this course, participants will be able to:
    • identify the role of hydroxychloroquine in standard of care lupus management.
    • describe the role of immunosuppressants and which ones to choose in SLE.
    • list the barriers to proper care in lupus patients.
    • differentiate the patients that my benefit from voclosporin and belimumab for lupus nephritis.
    •  research new therapies in the pipeline and how they may benefit patients with SLE.
    Target Audience
    This course is intended for primary care physicians, internal medicine physicians, rheumatologists, nurse practitioners, physician assistants, residents in internal medicine, rheumatologist fellows, and other health care providers

     

     Topics:


    *Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below
    • 2023 Lupus brochure.pdf
    • Deadliest Catch- a NETs story from SLE and APS to COVID-19.pdf
    • Emerging Therapeutics in SLE.pdf
    • How Does Diet Influence Systemic Lupus Erythematosus.pdf
    • November 18 Full Live.mp4 (3 hours 30 minutes)
    • Understanding Disparities in Systemic Lupus Erythematosus- Barriers and Opportunities for Improvement.pdf

     

    *Detail:

    • 8:30 Welcome and Announcements Hiroshi Kato, MD
    • 8:35 How Does Diet Influence Systemic Lupus Erythematosus  Aaron Stubbs, MD
    • 9:20 Deadliest Catch: a NETs story from SLE and APS to COVID-19 Ray Zuo, MD
    • 10:05 Break
    • 10:25 Understanding Disparities in Systemic Lupus Erythematosus: Barriers and Opportunities for Improvement Ashira Blazer, MD
    • 11:10 Emerging Therapeutics in SLE Hiroshi Kato, MD
    • 12:00 pm Course Adjourns